| Q26775401 | A comprehensive review of amyotrophic lateral sclerosis |
| Q60912737 | Amyotrophic Lateral Sclerosis and its Mimics/Variants: A Comprehensive Review |
| Q55877676 | Amyotrophic lateral sclerosis |
| Q56531747 | Amyotrophic lateral sclerosis |
| Q59219368 | Amyotrophic lateral sclerosis |
| Q35293000 | Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron |
| Q36202825 | Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole |
| Q84949206 | Amyotrophic lateral sclerosis mimic syndrome due to a dorsal spinal cord neurofibroma |
| Q26744171 | Amyotrophic lateral sclerosis mimic syndromes |
| Q28744223 | Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells |
| Q22305918 | Amyotrophic lateral sclerosis: considerations on diagnostic criteria |
| Q36278310 | Amyotrophic lateral sclerosis: update and new developments. |
| Q34343074 | Analysis of inconsistencies in terminology of spinal and bulbar muscular atrophy and its effect on retrieval of research |
| Q37523903 | Biomarkers in amyotrophic lateral sclerosis: facts and future horizons |
| Q37944427 | Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations |
| Q35928735 | CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy |
| Q38007362 | CSF markers in amyotrophic lateral sclerosis |
| Q48265513 | CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis |
| Q41478204 | Cervicothoracic intradural arachnoid cyst misdiagnosed as motor neuron disease. |
| Q82029191 | Chapter 12 Multifocal and other motor neuropathies |
| Q82029198 | Chapter 13 Amyotrophic lateral sclerosis |
| Q64228443 | Clinical Measures of Bulbar Dysfunction in ALS |
| Q91786616 | Clinical Mimickers of Amyotrophic Lateral Sclerosis-Conditions We Cannot Afford to Miss |
| Q36947727 | Clinical care of patients with amyotrophic lateral sclerosis |
| Q37944429 | Clinical diagnosis and management of amyotrophic lateral sclerosis |
| Q37831814 | Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature |
| Q34041957 | Cryptorchism |
| Q61798717 | Diagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis |
| Q24799677 | Geographical and seasonal correlation of multiple sclerosis to sporadic schizophrenia |
| Q92813735 | Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment |
| Q58617336 | Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 |
| Q42273018 | Kennedy disease with difficulty in differential diagnosis: A case report. |
| Q64087673 | Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions |
| Q37165524 | Management of amyotrophic lateral sclerosis |
| Q38272668 | MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis |
| Q39281105 | Motor neurone disease: a practical update on diagnosis and management |
| Q38087612 | Motor neurone disease: diagnostic pitfalls. |
| Q81679400 | Multifocal motor neuropathy |
| Q37959252 | Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies |
| Q41272501 | Multimodal structural MRI in the diagnosis of motor neuron diseases |
| Q35214943 | Nuclear localization of SMN and FUS is not altered in fibroblasts from patients with sporadic ALS |
| Q36758791 | Pearls & Oy-sters: The importance of atypical features and tracking progression in patients misdiagnosed with ALS |
| Q36129336 | Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor. |
| Q81506833 | Quantitative muscle ultrasonography in amyotrophic lateral sclerosis |
| Q26749521 | Recent advances in amyotrophic lateral sclerosis |
| Q64119028 | Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts-Novel Techniques |
| Q35143367 | The basic aspects of therapeutics in amyotrophic lateral sclerosis |
| Q35875329 | The clinical spectrum of isolated peripheral motor dysfunction |
| Q36441993 | The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials |
| Q44834663 | The epidemiology of motor neurone disease in two counties in the southwest of England. |
| Q37395409 | The management of amyotrophic lateral sclerosis |
| Q35576475 | The management of motor neurone disease. |
| Q84229831 | [Motor neuron diseases] |